NewEdge Advisors’s BioLife Solutions BLFS Stock Holding History

NewEdge Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-233	Closed	-$4.24K	–	3500
2022 Q4	$4.24K	Buy	+233	New	+$4.81K	﹤0.01%	2647

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

NewEdge Advisors's BLFS Position: Q1 2023 in Review

NewEdge Advisors sold out of BioLife Solutions (BLFS) in Q1 2023, closing a stake of 233 shares — an estimated $4.24K sold.

NewEdge Advisors first reported a position in BLFS in Q4 2022 and held it in 1 quarter. The position peaked at $4.24K in Q4 2022. 169 funds tracked by Wall St. Rank hold BLFS as of Q1 2023.

NewEdge Advisors reported no remaining BioLife Solutions position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 233 BioLife Solutions shares in Q1 2023, an estimated $4.24K.
NewEdge Advisors first reported a position in BioLife Solutions in Q4 2022 and held it in 1 quarter.
NewEdge Advisors's BioLife Solutions position peaked at $4.24K in Q4 2022.
169 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.